Attention Laurel Patients:  The new Laurel office is open. The address is 7140 Contee Road, Suite 3500, Laurel, MD 20707….Attention Lanham/Largo Patients: Our new Largo office is now open and our Lanham location is closed permanently. Largo’s address is 9333 Healthcare Way Suite 4100 Largo, MD 20774.

HIPAA Alert:
Potential Data Breach : Learn More

Trial Protocol ID USOR 21462_GLSI-21-01_FLAMINGO

Trial Description

A Randomized, Multicenter, Placebo-controlled, Phase 3 study to Evaluate the Efficacy and Safety of HER2/neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/neu Positive Subjects with Residual Disease or High-Risk PCR after both Neoadjuvant and Postoperative Trastuzumab-based Therapy (FLAMINGO-01)

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Jeanine L Werner, M.D.

Disease Types

Sponsor

  • Greenwich Life Sciences

ClinicalTrials.gov NCT ID

  • NCT05232916